REMEGEN CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 30.5 HKD | +0.83% |
|
+10.11% | -18.56% |
| Apr. 26 | RemeGen Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Apr. 04 | Remegen Gets US FDA Fast Track Designation for Primary Sjögren's Syndrome Medication | MT |
Chart calendar RemeGen Co., Ltd.
d0181025bfb3f72f079c7bb922f.2mpn3F-m_RTkNn5ABPthdnDWmHkh7ybOHzHO3X0nzKk.qCsKnTXrkka1Yg8GfZMAIxrgq00QjE6UKGKGmh9wnu2fJS2kFvnNTYJYOw~82a883999c473c03e043988fb7a51e0b
Upcoming events on RemeGen Co., Ltd.
Past events on RemeGen Co., Ltd.
| 2024-04-25 | Q1 2024 Earnings Release |
| 2024-03-26 | Q4 2023 Earnings Release |
| 2023-11-15 10:30 am | American College of Rheumatology Conference |
| 2023-10-29 | Q3 2023 Earnings Release |
| 2023-08-21 | Q2 2023 Earnings Release |
| 2023-05-08 | Macquarie DELTAH China Conference |
| 2023-04-26 | Q1 2023 Earnings Release |
| 2023-03-28 | Q4 2022 Earnings Release |
| 2022-11-02 | American Society of Nephrology Kidney Week Conference |
| 2022-10-26 | Q3 2022 Earnings Release |
| 2022-08-30 | Interim 2022 Earnings Release |
| 2022-06-03 | American Society of Clinical Oncology Meeting |
| 2022-04-26 | Q1 2022 Earnings Release |
| 2022-03-28 | FY 2021 Earnings Release |
| 2021-12-20 01:00 am | Extraordinary Shareholders Meeting |
| 2021-08-22 | Interim 2021 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million CNY | Released Forecast Spread | 0,00 | 0,00 0,00 - | 1 426 1 193 19.56% | 768 828 -7.29% | 1 083 1 129 -4.09% | 1 641 |
|
EBITDA Million CNY | Released Forecast Spread | 0,00 | -606 -449 -34.89% | 366 67,1 445.5% | -794 -797 0.34% | -1 322 -1 043 -26.73% | -1 047 |
|
EBIT Million CNY | Released Forecast Spread | 0,00 | -669 -506 -32.09% | 282 5,51 5014.41% | -981 -966 -1.5% | -1 502 -1 116 -34.59% | -1 157 |
|
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | 0,00 | -698 -594 -17.42% | 276 333 -17.1% | -999 -912 -9.56% | -1 511 -1 209 -25.04% | -1 225 |
|
Net income Million CNY | Released Forecast Spread | -430 | -698 -589 -18.4% | 276 54,4 407.38% | -999 -965 -3.53% | -1 511 -1 417 -6.66% | -1 148 |
|
EPS CNY | Released Forecast Spread | 0,00 | -1,42 -1,24 -14.84% | 0,57 -0,09 762.33% | -1,88 -1,82 -3.38% | -2,86 -2,24 -27.42% | -2,11 |
| Announcement Date | 28/10/20 | 26/03/21 | 20/02/22 | 27/02/23 | 23/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 S1 | 2021 S2 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2022 S2 | 2023 Q1 | 2023 Q4 | 2023 S2 |
|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million CNY | Released Forecast Spread | 1 397 1 446 -3.38% | 198 206 -3.82% | 419 427 -1.87% | 361 | 711 | ||||
|
Earnings before Tax (EBT) Million CNY | Released Forecast Spread | 720 709 1.59% | -220 | -510 -419 -21.65% | 520 | 847 | ||||
|
Net income Million CNY | Released Forecast Spread | -444 | -489 | -199 | -220 | -510 -419 -21.65% | -324 | -520 | -847 | |
|
EPS CNY | Released Forecast Spread | -0,91 | -0,96 | -0,36 | -0,60 | |||||
| Announcement Date | 23/08/21 | 20/02/22 | 30/08/22 | 27/10/22 | 27/02/23 | 27/02/23 | 27/04/23 | - | - |
More events
Past sector events for RemeGen Co., Ltd.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 9995 Stock
- Calendar RemeGen Co., Ltd.
